Journal Article DKFZ-2020-02393

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Differential transcriptome response to proton versus X-ray radiation reveals novel candidate targets for combinatorial PT therapy in lymphoma.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2021
Elsevier Science Amsterdam [u.a.]

Radiotherapy and oncology 155, 293-303 () [10.1016/j.radonc.2020.10.024]
 GO

This record in other databases:  

Please use a persistent id in citations: doi:

Abstract: Knowledge of biological responses to proton therapy (PT) in comparison to X-ray remains in its infancy. Identification of PT specific molecular signals is an important opportunity for the discovery of biomarkers and synergistic drugs and improved PT clinical usage. As PT can be used for lymphoma treatment, we study here lymphoma cell lines transcriptomic response to PT vs X-ray to identify potential drugable target.Two different human (BL41) and murine (J3D) lymphoma cell lines were irradiated X-ray and PT. Differential transcriptome regulation was evaluated by RNA sequencing for each radiation type at 12 hours post irradiation. Gene-set enrichment analysis was used to discover potentially deregulated molecular pathways and potential targets for lymphoma cells sensitization to PT.Transcriptomic. Gene set enrichment analyses discovered pathways that contribute to the unfold protein response and mitochondrial transport. Functional validation showed increased UPR activation and decreased protein translation perhaps due to increased oxidative stress and oxidative protein damage after PT. PPARgamma was identified as a potential regulator of PT transcriptomic response. Inhibition of PPARgamma by T0070907 and SR2595 compounds sensitized lymphoma cells to PT.Proton vs X-ray led to the transcriptional deregulation of a specific subset of genes that is functionally in line with diminished protein translation, UPR activation and increased oxidative stress. This study demonstrates that radiation types trigger distinct molecular responses in lymphoma cells and identifies PPARgamma inhibition as a potential strategy for sensitization of lymphoma to PT.

Classification:

Note: 2021 Feb;155:293-303

Contributing Institute(s):
  1. DKTK HD zentral (HD01)
  2. E210 Translationale Radioonkologie (E210)
  3. E050 KKE Strahlentherapie (E050)
Research Program(s):
  1. 315 - Bildgebung und Radioonkologie (POF4-315) (POF4-315)

Appears in the scientific report 2021
Database coverage:
Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Public records
Publications database

 Record created 2020-11-05, last modified 2024-02-29



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)